Filing Details

Accession Number:
0001477932-20-000068
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-06 15:59:27
Reporting Period:
2019-12-30
Accepted Time:
2020-01-06 15:59:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1622057 Nascent Biotech Inc. NBIO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1479734 Thomas Lowell Holden 6330 Nancy Ridge Dr.
Suite 105
San Diego CA 92121
Cfo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock (Conversion Of Debt To Equity) Acquisiton 2019-12-30 830,000 $0.10 2,230,357 No 4 J Direct
Common Stock Acquisiton 2019-12-30 56,700 $0.10 2,287,057 No 4 J Direct
Common Stock Acquisiton 2019-12-26 5,000 $0.17 2,292,057 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 J Direct
No 4 J Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,312,057 Indirect By Spouse
Footnotes
  1. The shares were granted as part of the employment contract with the Company.